Evidence map›Paper›PMID 17804505›Full record

ArticleJournal of virology2007

Fas ligand interactions contribute to CD8+ T-cell-mediated control of West Nile virus infection in the central nervous system.

Bimmi Shrestha, Michael S Diamond

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Journal of virology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05568953 (An Experimental Medicine Decipher of a Minimum Correlate of Cellular Immunity), which is not on this map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05568953 phase2unknown statusnot on this mapstarted 2022, after this paper: background citation

An Experimental Medicine Decipher of a Minimum Correlate of Cellular Immunity

TypeinterventionalSponsorSingapore General HospitalRan2022 to 2025Enrolled70ConditionsInfectious Disease, Yellow Fever, Japanese Encephalitis, Viral InfectionArmsStamaril, Imojev, Ixiaro
3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 103 citations in OpenAlex.

  1. Trial
  2. IL-21 controls CD8Zoological research · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Antigen non-specific CD8bioRxiv : the preprint server for biology · 2024
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. The role of antiviral CD8Current opinion in neurobiology · 2022
    Review
  18. Article
  19. Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 2 countries.

Bimmi ShresthaDepartment of Medicine, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, USA.
Michael S Diamond
Washington University in St. Louis · US

Funding

Virology and Smallpox VaccinationsU54AI057160 · NIAID · WASHINGTON UNIVERSITY · PI OLDSTONE, MICHAEL B · 2003 to 2013
$80.9M
NIAID NIH HHS U54 AI 057160NIAID NIH HHS U54 AI057160
6 · The paper itself

Abstract

West Nile virus (WNV) is a neurotropic flavivirus that causes encephalitis, most frequently in elderly and immunocompromised humans. Previous studies demonstrated that CD8+ T cells utilize perforin-dependent cytolytic mechanisms to limit WNV infection. Nonetheless, the phenotype of perforin-deficient CD8+ T cells was not as severe as that of an absence of CD8+ T cells, suggesting additional effector control mechanisms. In this study, we evaluated the contribution of Fas-Fas ligand (FasL) interactions to CD8+ T-cell-mediated control of WNV infection. Notably, the cell death receptor Fas was strongly upregulated on neurons in culture and in vivo after WNV infection. gld mice that were functionally deficient in FasL expression showed increased susceptibility to lethal WNV infection. Although antigen-specific priming of CD8+ T cells in peripheral lymphoid tissues was normal in gld mice, increased central nervous system (CNS) viral burdens and delayed clearance were observed. Moreover, the adoptive transfer of WNV-primed wild-type but not gld CD8+ T cells to recipient CD8(-/-) or gld mice efficiently limited infection in the CNS and enhanced survival rates. Overall, our data suggest that CD8+ T cells also utilize FasL effector mechanisms to contain WNV infection in Fas-expressing neurons in the CNS.

Indexed as

Gene Expression Regulation, ViralAnimalsCD8-Positive T-LymphocytesCentral Nervous System InfectionsCricetinaeFas Ligand ProteinHumansInterferon-gammaLigandsMiceMice, Inbred C57BLModels, BiologicalNeuronsWest Nile FeverWest Nile virusFas Ligand ProteinInterferon-gammaLigands

Identifiers

PMID17804505
PMCPMC2168805
OpenAlexW2124078703

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.